首页> 美国卫生研究院文献>Frontiers in Chemistry >How Reliable Are Ligand-Centric Methods for Target Fishing?
【2h】

How Reliable Are Ligand-Centric Methods for Target Fishing?

机译:以目标为目标的配体为中心的方法的可靠性如何?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Computational methods for Target Fishing (TF), also known as Target Prediction or Polypharmacology Prediction, can be used to discover new targets for small-molecule drugs. This may result in repositioning the drug in a new indication or improving our current understanding of its efficacy and side effects. While there is a substantial body of research on TF methods, there is still a need to improve their validation, which is often limited to a small part of the available targets and not easily interpretable by the user. Here we discuss how target-centric TF methods are inherently limited by the number of targets that can possibly predict (this number is by construction much larger in ligand-centric techniques). We also propose a new benchmark to validate TF methods, which is particularly suited to analyse how predictive performance varies with the query molecule. On average over approved drugs, we estimate that only five predicted targets will have to be tested to find two true targets with submicromolar potency (a strong variability in performance is however observed). In addition, we find that an approved drug has currently an average of eight known targets, which reinforces the notion that polypharmacology is a common and strong event. Furthermore, with the assistance of a control group of randomly-selected molecules, we show that the targets of approved drugs are generally harder to predict. The benchmark and a simple target prediction method to use as a performance baseline are available at .
机译:目标捕捞(TF)的计算方法,也称为目标预测或多药理学预测,可用于发现小分子药物的新目标。这可能导致将药物重新定位为新的适应症或改善我们目前对其功效和副作用的了解。尽管对TF方法有大量研究,但仍需要改进其验证,这通常限于可用目标的一小部分,并且用户不易理解。在这里,我们讨论以目标为中心的TF方法如何固有地受可能预测的目标数量的限制(此数量在以配体为中心的技术中通过构造要大得多)。我们还提出了一个新的基准来验证TF方法,该基准特别适合分析预测性能如何随查询分子而变化。平均而言,超过批准的药物,我们估计仅需测试五个预测目标即可找到具有亚微摩尔效价的两个真实目标(但是,观察到性能差异很大)。此外,我们发现,已获批准的药物目前平均具有八个已知的靶标,这强化了多药理学是常见且重要的事件的观念。此外,在随机选择的分子对照组的协助下,我们表明,批准药物的靶标通常较难预测。可以使用基准和用作性能基准的简单目标预测方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号